Rx (Prescription Medicine)
USD $ 120.00
Mygem 200mg Injection 是一种关键药物，主要用于治疗与免疫系统调节及特定癌症相关的各种情况。其活性成分为 Gemcitabine，属于核糖类似物，通过干扰 DNA 合成，从而抑制癌细胞的生长。通常以静脉注射方式在医护人员的监督下使用。
Mygem 200mg Injection 的适应症包括胰腺癌、非小细胞肺癌、乳腺癌和卵巢癌的治疗。剂量及治疗时长由主治医生根据患者的具体病情、对疗法的反应以及整体健康状况来确定。
常见不良反应可能包括疲劳、恶心、呕吐、发热、脱发以及骨髓抑制，导致血细胞计数下降。患者还可能出现类似流感的症状。如出现任何不寻常或严重的不良反应，请立即向医生报告。
Mygem 200mg Injection 应储存在室温，避光防潮。务必遵循制造商及医护人员提供的所有储存说明。本药仅应由受过专业训练的人员进行给药。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Pack Quantity | |
| Packaging Type |
其他品牌的 Gemcitabine 200 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
